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in Thymocyte Migration and 
Development
Wilson Savino* , Daniella Arêas Mendes-da-Cruz , Daiane Cristina Ferreira Golbert ,  
Ingo Riederer and Vinicius Cotta-de-Almeida
Laboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
Intrathymic T-cell differentiation is a key process for the development and maintenance of 
cell-mediated immunity, and occurs concomitantly to highly regulated migratory events. 
We have proposed a multivectorial model for describing intrathymic thymocyte migra-
tion. One of the individual vectors comprises interactions mediated by laminins (LMs), 
a heterotrimeric protein family of the extracellular matrix. Several LMs are expressed in 
the thymus, being produced by microenvironmental cells, particularly thymic epithelial 
cells (TECs). Also, thymocytes and epithelial cells express integrin-type LM receptors. 
Functionally, it has been reported that the dy/dy mutant mouse (lacking the LM isoform 
211) exhibits defective thymocyte differentiation. Several data show haptotactic effects of 
LMs upon thymocytes, as well as their adhesion on TECs; both effects being prevented 
by anti-LM or anti-LM receptor antibodies. Interestingly, LM synergizes with chemokines 
to enhance thymocyte migration, whereas classe-3 semaphorins and B ephrins, which 
exhibit chemorepulsive effects in the thymus, downregulate LM-mediated migratory 
responses of thymocytes. More recently, we showed that knocking down the ITGA6 
gene (which encodes the α6 integrin chain of LM receptors) in human TECs modulates a 
large number of cell migration-related genes and results in changes of adhesion pattern 
of thymocytes onto the thymic epithelium. Overall, LM-mediated interactions can be 
placed at the cross-road of the multivectorial process of thymocyte migration, with a 
direct influence per se, as well as by modulating other molecular interactions associated 
with the intrathymic-trafficking events.
Keywords: thymus, T-cell development, T-cell migration, thymic epithelial cells, extracellular matrix, laminin 
isoforms, integrins, chemokines
iNTRODUCTiON
The thymus plays a central role on the immune system, as the primary lymphoid organ where 
T  lymphopoiesis takes place (1, 2). It is responsible for generating lymphocytes that exhibit a diverse 
group cells expressing the T-cell receptor (TCR), including the conventional CD4+ and CD8+ TCRαβ 
T cells, TCRγδ T cells, Foxp3+ regulatory T cells, and the invariant NK T cells (3). Along with this 
whole process, the thymus stems a complex set of differentiating signals that target bone marrow-
derived lymphoid progenitors which settle the thymus to become committed to T-cell lineage and 
further originating those distinct T-cell lineages (4). In this context, intrathymic T-cell  differentiation 
is considered a key process for the development and maintenance of cell-mediated immune responses. 
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Accordingly, bone marrow-derived T-cell precursors enter the 
thymus where they undergo a complex series of biological events, 
so that around 95% of the cells generated within the organ die by 
apoptosis. Meanwhile, a small proportion of cells is rescued from 
programed cell death and acquires the ability to exit the organ, 
ultimately reaching the thymus-dependent areas of the secondary 
lymphoid organs Figure 1A [reviewed in Ref. (5–7)]. These mature 
T cells are then able to mount a cell-mediated immune response.
The developmental journey that generates the conventional 
CD4+  and CD8+ αβ T cells has been extensively studied and 
involves a series of ordered proliferative and selective events, 
under the central influence of gene recombination at the TCR 
loci, that results in pre-TCR and αβ TCR assembling (8). The 
pathway starts after progenitor cells enter the thymus at the so-
called corticomedullary junction and migrate from the cortex in 
the direction to the subcapsular area as cells lacking CD4 and 
CD8 coreceptors, defined as double-negative (DN; CD4−CD8−) 
thymocytes. Here, the TCR rearrangement is tested through 
the expression of a pre-TCR, in a process called β-selection (9). 
Following the TCRα chain assembly at the highly expanded 
double-positive (DP; CD4+CD8+) stage, TCR specificity is tested 
in a process known as positive selection, where low-avidity inter-
actions with self peptide–MHC complexes expressed on thymic 
epithelial cells (TECs) allow survival and further differentiation 
(10, 11). The differentiating DP thymocytes start to lose the 
expression of either CD4 or CD8 and migrate from the cortex 
toward the thymic medulla. The pathways leading to CD4 or CD8 
SP subsets are dependent on distinct transcriptional machiner-
ies, seem to initiate at the transitional stage characterized as 
CD4+CD8lo, and depend on the TCR interaction with MHC class 
II or class I [reviewed in Ref. (12–14)].
The most critical developmental cues arise from the tissue 
microenvironment. In this context, thymic microenvironmental 
cells – comprising cortical and medullary TECs as well as other 
stromal cells of mesodermal origin – provide the milieu for T-cell 
development and the final selection of a proper set of the T-cell 
repertoire (15).
The microenvironmental signals include cell surface and 
soluble molecules, such as Delta-class Notch ligand Delta-like 
4 (Dll4), kit ligand, MHC molecules, and interleukin-7 (IL-7). 
Likewise, as intrathymic T-cell differentiation occurs concomi-
tantly to highly regulated migratory events, chemokine-derived 
signals are present from the progenitor entrance until the exit of 
mature SP cells for the periphery (7, 16, 17). In fact, as discussed 
below, we have proposed a multivectorial model for describing 
intrathymic migration of developing thymocytes (18).  In this 
context, interactions with the extracellular matrix (ECM) also 
critically operate throughout the intrathymic T-cell maturational 
pathway (19).
Thymic epithelial cells are the major cellular component of 
the thymic microenvironment and are located in both the cortex 
(cTEC) and medulla (mTEC) of the thymic lobules. A special 
lymphoepithelial complex named thymic nurse cells (TNC) is 
located in the outer cortex and can be used as an in vitro model 
to study thymocyte migration in a tridimensional TEC context 
(16). In the medulla, a particular mTEC component is able to 
express the transcription factor autoimmune regulator which 
controls the thymic expression of so-called tissue-specific 
FiGURe 1 | Simplified diagrams of thymocyte differentiation and migration, in the context of the thymic microenvironment, according to a 
multivectorial migratory pattern. In (A), we show that bone marrow-derived T-cell precursors enter the thymus through blood vessels (BV) in the corticomedullary 
junction of thymic lobules. CD4−CD8− double negative (DN) immature thymocytes then migrate to the outer cortex, where they interact with cortical thymic epithelial 
cells (cTEC) and differentiate into CD4+CD8+ double positive (DP) cells. These cortical thymocytes will be able to continue to interact with microenvironmental cells 
as they migrate to the medulla, and positively selected cells will become either CD4 single-positive (CD4 SP) or CD8 single-positive (CD8 SP) cells, by interacting 
with medullary TEC (mTEC) or dendritic cells (DC) the medulla. In addition to cell–cell interactions between thymocytes and the microenvironmental components, 
developing thymocytes can be influenced by components of the extracellular matrix (herein labeled with blue crosses). Mature SP thymocytes will leave the organ by 
entering blood vessels that will allow them to find the way to colonize the T-cell-dependent zones of peripheral lymphoid organs. Although not showed in the 
cartoon, most thymocytes actually die and are rapidly phagocytized by macrophages. In (B), we illustrate that thymocyte migration occurs as a result of multiple 
interactions, following a multivectorial pattern throughout the thymic lobule. In this panel, we emphasize the importance of LM (the red crosses) as one vector 
involved in thymocyte migration, comprising both immature and mature cells. Diagrams modified from Ref. (16, 18, 81, 128, 129).
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antigens, and this interaction is important for avoiding autoim-
munity (20, 21).
As seen below, microenvironmental cells are responsible to 
produce the ECM network in the thymus, as well as other cell 
migration-related moieties, such as chemokines (16, 19).
In this review, we specifically highlight the role of laminin 
(LM) isoforms for intrathymic T-cell migration and maturation 
in both physiological and pathological conditions.
iNTRATHYMiC eXPReSSiON OF  
LM iSOFORMS AND iNTeGRiN-TYPe LM 
ReCePTORS
Laminins correspond to a family of heterotrimeric ECM proteins 
formed by an α, β and γ chain; each being encoded by a specific 
gene. Several LM isoforms have been described and are classi-
fied according to the corresponding α, β, and γ chains. Once 
synthesized, the chains form a cross-shaped coiled-coil structure. 
Currently, five α, three β, and three γ chains have been chemically 
characterized, and 18 isoforms reported (see Table 1). The cur-
rent nomenclature uses Arabic numerals based on the three chain 
numbers. For example LM-111 is formed by α1, β1, and γ1 chains, 
whereas LM-211 is composed by α2, β1, and γ1 chains (22–24).
Laminin-mediated interactions are triggered by two main 
classes of receptors, integrin- and non-integrin-type receptors 
TABLe 1 | Laminin isoforms and corresponding integrin-type laminin 
receptors a.
Laminin isoforms Composition  
(α, β, and γ 
chains)
Preferential integrin 
receptors
Present 
nomenclature
Previous 
nomenclature
LM-111 Laminin-1 α1β1γ1 α1β1, α2β1, α3β1 
α6β1, α6β4, and α7β1
LM-121 Laminin-3 α1β2γ1 α6β1, α6β4, and α7β1
LM-211 Laminin-2/
merosin
α2β1γ1 α6β1, α3β1, α6β4, 
and α7β1
LM-212 – α2β1γ2 α3β1, α6β1, and α7β1
LM-222 – α2β2γ2 α3β1, α6β1, and α7β1
LM-213 Laminin-12 α2β1γ3 –
LM-221 Laminin-4 α2β2γ1 α7β1
LM-311 Laminin-6/
Laminin-6A
α3β1γ1 α3β1 and α6β1 
LM-321 Laminin-7/
laminin-7A
α3β2γ1 ND
LM-323 Laminin-13 α3β2γ3 –
LM-332 Laminin-5 α3Bβ2γ1 α1β1, α3β1, α6β1, 
and α6β4
LM-411 Laminin-8 α4β1γ1 α3β1, α6β1, and α7β1
LM-421 Laminin-9 α4β2γ1 α6β1
LM-423 Laminin-14 α4β2γ3 –
LM-511 Laminin-10 α5β1γ1 α3β1, α6β1, and α6β4
LM-521 Laminin-11 α5β2γ1 α3β1, α6β1, and α6β4
LM-522 – α5β2γ2 α3β1
LM-523 Laminin-15 α5β2γ3 –
aData adapted from Ref. (25–40).
ND, not determined; – absence of integrin binding because of the γ3 chain of the  
LM isoform (27).
(41, 42). At least eleven integrins, namely α1β1, α2β1, α2β2, 
α3β1, α6β1, α6β4, α7β1, α9β1, αvβ3, αvβ5, αvβ8, and αMβ2, can 
bind to LMs (25, 43–49). Moreover, there is, to some extent, a 
specificity of given integrins to bind different LMs. For example, 
the integrins α6β1 and α3β1 (CD49f/CD29 and CD49c/CD29, 
respectively) recognize both LM-511 and LM-521 (26). A second 
integrin bearing the α6 subunit, the α6β4 LM receptor (CD49f/
CD104), presents the highest affinity for LM-3A32 (26).
Upon LM, binding integrins acts through outside-in signaling, 
promoting modulation in phosphorylation states and activities of 
cytosolic tyrosine kinases, such as focal adhesion kinase and Src 
family kinases, which subsequently regulate other kinases, scaf-
folding proteins, and intracellular signal transduction (50, 51). 
Such signaling is initially triggered by the binding of the globular 
domains of LM α-chains to integrins (24). In this respect, LM iso-
forms containing the γ3 chain are unable to bind to integrins due 
to the absence of the glutamic acid residue, which is conserved in 
the C-terminal regions of the γ1 and γ2 chains (27).
The list of LM isoforms and corresponding integrin-type 
receptors so far described is summarized in Table  1, and the 
general gene and protein features, as well as functions in the 
hemopoietic system can be fully accessed at the LM Database 
Version 2.0: www.lm.lncc.br (28).
Laminins are heterogeneously distributed within the thymic 
lobules. The initial immunolocalization studies, using anti-LM 
polyclonal antibodies that do not discriminate a specific LM 
isoform, revealed a heterogeneous distribution, with the medulla 
containing a denser LM network as compared to the cortex (52). 
Additionally, perivascular spaces (PVS) as well as periseptal 
basement membranes contain LM. This distribution pattern is 
observed in both human and mouse thymuses (52–54). Moreover, 
in vitro studies revealed that TECs, as well as phagocytic cells of 
the thymic reticulum, are able to produce LM (52, 53, 55).
Gene expression analyses revealed that genes coding for sev-
eral LM chains are constitutively expressed in the human thymus 
(29, 56, 57). Moreover, taking advantage of the availability of 
antibodies able to specifically discriminate LM chains, isoforms 
could be more precisely located within the thymus.
Laminin-111 appears early and is the main LM isoform during 
embryogenesis (58–60). However, in adults, LM-111 expression 
is very limited, being detected in some epithelial basement mem-
branes (61, 62). Interestingly, although PCR amplification from 
bulk thymus extracts did not reveal the α1 LM chain (29, 57), 
it was clearly identified in extracts obtained from cultured TEC 
or TNC (57). This result points to the possibility that particular 
culture conditions may modify the expression of LM chains. 
Moreover, In addition to its role in thymocyte migration (further 
discussed below), LM-111 is able to stimulate the proliferation 
both mouse and human TEC (53, 63).
Laminin-211 (formerly called merosin) is present in the base-
ment membrane of the skeletal muscle (64) and also occurs in 
different organs, including the mouse and human thymus (29, 30, 
57). The α2 LM chain is observed in the subcapsular epithelium 
and blood vessels of human thymus (29); being also detected in 
cultures of TEC and TNC complexes (57). In mice, immature 
thymocytes bind more to LM-211 when compared to mature 
ones, and use the α6β1 integrin, rather than α6β4 to adhere to this 
TABLe 2 | In situ intrathymic expression of laminin isoformsa.
Laminin 
isoformsb
Subcapsular 
cortex
inner 
cortex
Medulla Perivascular
LM-211 + − − +
LM-221 + − − +
LM-332 + − + −
LM-411 − − − +
LM-421 − − − +
LM-511 + − − +
LM-521 + − − +
aData compiled from Ref. (29, 31, 55, 56, 68, 69).
bWe did not find any published report concerning the intrathymic localization of other 
LM isoforms, despite some LM chains were detected in thymic bulk extracts.
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isoform (30). Human thymocytes express both α6β1 and α3β1 
integrin-type LM receptors, which mediate the binding to this 
isoform and are involved in thymocyte proliferation triggered 
by a costimulatory signal from anti-CD3 antibody plus LM-211 
(31). However, differently from these results, it has been reported 
that none of the thymocyte subpopulations bind to LM-211 or 
LM-221 (29). Such discrepancy may be due to different experi-
mental conditions, or even the quality of the LM preparations.
However, in vivo data revealed that mice spontaneously lacking 
LM-211 (dy/dy) show a disorganized and smaller thymus, with a 
reduced number of thymocytes, particularly in DP subpopula-
tion. In these animals, capsular and subcapsular DN thymocytes 
exhibit increase in apoptosis (65). Using another α2 LM mutant 
mouse (dy3k/dy3k), an apoptosis-related decrease in the DP subset 
was also reported. Furthermore, LM-211 increased the viability 
of normal thymocytes (66). Interestingly, the lack of LM-211 in 
the animals also compromises the functional innervation of the 
organ, since the acetylcholinesterase activity of the dy/dy mouse 
thymus is decreased in 50% as compared to age/matched normal 
(67). Taken together, these data indicate a pleiotropic effect of 
LM-211 upon the thymus.
Studies on the distribution of LM-332, using reagents able 
to define the localization of α3, β3, and γ2 LM chains, revealed 
that such isoform is present in the medullary area of the thymic 
parenchyma and the basal laminae of the subcapsular cortex and 
of blood vessels. More precisely, LM-332 was localized in epi-
thelial cells (defined by keratin staining) and surrounding blood 
vessels, including capillaries (29, 56). Three-dimensional recon-
struction of human thymic lobules, using confocal microscopy 
after immunohistochemical staining revealed a sort of LM-332-
containing conduit structure surrounded by TECs in the medulla 
of the thymic lobules. In these conduits, immunohistochemistry 
staining with polyclonal antibodies for LM from Engelbreth-
Holm-Swarm murine sarcoma basement membrane, which do 
not recognize LM-332, indicates that other LM isoforms can be 
present. Indeed, TEC primary cultures, but not thymic dendritic 
cells that also surround the conduits, express the LM chains 
containing the isoform 332. Measurements of these structures 
revealed that they are too narrow to allow a flow of cells, thus 
raising the hypothesis that they provide an influx of molecules in 
the thymic medulla (68). Yet, experimental evidence to prove this 
possibility remains to be obtained.
Functionally, it has been shown that soluble LM-332 inhibits 
human thymocyte proliferation induced by anti-CD3 plus 
IL-2 (56). In another work, CD8+ SP thymocytes were the only 
subpopulation able to adhere onto LM-332, being this adhesion 
dependent of α6β4 integrin (29). These results indicate that this 
isoform can be involved in the differentiation of the more mature 
subpopulations from the thymus. Interestingly, this is in opposite 
to the LM containing the α2 chain, which are located in the sub-
capsular region and functionally seems to affect more immature 
subpopulations.
Gene expression for α3, β3, and γ2 LM chains (which form 
LM-332) was also detected in the mouse thymus. Nevertheless, 
at variance with the pattern reported for humans, in the mouse 
thymus, in situ hybridization together with immunohistochemi-
cal studies revealed a more restricted distribution of this LM 
isoform, only in the outer cortex of the thymic lobules (69). The 
discrepancies concerning LM-332 distribution in the thymus of 
these species remain to be elucidated. They can be real biological 
differences, or they can derive from differences in the reagents 
applied. In any case, using anti-LM-332 blocking antibodies in 
fetal thymus organ cultures, the authors found an arrest in T-cell 
development at the DN stage of differentiation, thus unraveling 
the role of this isoform in thymus physiology (69).
Laminin isoforms containing α4 and α5 chains are the main 
isoforms found in the basal membranes of the endothelium (70). 
Accordingly, in the human thymus, α4 LM chain is restricted to 
the endothelium, as defined by anti-PECAM staining, with the 
isoforms 411 and 421 present in the blood vessels (29). However, 
PCR analysis of TEC and TNC bulk extracts in culture suggests 
the presence of LM containing the α4 chain (57), also indicating 
that particular culture conditions may modify the expression of 
LM chains.
Laminin-511 is widely distributed in the body and, in the 
basement membrane of the blood vessels, LM-511 and LM-521 
are normally associated with the isoform 411 (70). In the thymus, 
the α5 LM chain was observed in the subcapsular epithelium of 
the thymic lobules and in the thymic blood vessels, together 
with LM-411. Functionally, in  vitro experiments showed that 
the thymocytes binding to LM-511 was mediated by the integrin 
α6β1, with a preferential adhesion of DN thymocytes to LM-511/
LM-521 (29).
If in one hand LM isoforms containing the α2, α4, and α5 
chains can be detected in thymic blood vessels, the expression 
of the isoform LM-332 (containing the α3 and γ2 chains) seems 
to be a main feature of mTEC (29, 56). It is thus conceivable that 
distinct LM isoforms play specific roles in the intrathymic T-cell 
differentiation and migration.
Overall, the RT-PCR analysis of human LM isoform gene 
expression together with immunohistochemical data on tissue 
sections and cultured TEC and TNC showed that genes coding 
for LM components are actively transcribed both in  situ and 
in TEC cultures, and actually the corresponding polypeptides 
are assembled to form the respective isoforms (29, 56, 57). It 
is important to mention that the studies employing PCR from 
thymus bulk extracts suggest the presence of LM-211, LM-332, 
LM-411, and LM-511, which are already described in situ, using 
specific antibodies for the LM chains (see Table 2). Additionally, 
TABLe 3 | expression of integrin-type laminin receptors by developing thymocytes and thymic microenvironmental cellsa.
Laminin receptorb CD4/CD8-defined developing thymocytesc Thymic microenvironmental cells
DN DP CD4 SP CD8 SP TeC TDC endo
α1β1 − − − − + ND +
α2β1 − − − − + + +
α2β2 ND ND ND ND + ND ND
α3β1 + − + + + ND +
α6β1 + + + + + ND ND
α6β4 + − + + + ND ND
α7β1 ND ND ND ND + ND ND
aData compiled from Ref. (63, 71–75).
bWe did not find any published report concerning the intrathymic expression of the following laminin-binding integrins: α9β1, αvβ3, αvβ5, αvβ8, and αMβ2.
cDN = CD4−CD8−; DP = CD4+CD8+; CD4 SP = CD4+CD8−; CD8 SP = CD4−CD8+.
TEC, thymic epithelial cell; TDC, thymic dendritic cell; Endo, endothelium; ND, not determined.
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these works suggest the presence of LM-311 and γ3-containing 
LM isoforms (29, 57). Yet, these studies are essentially based on 
the thymus sections from infants, and the knowledge on fetal as 
well as aging thymus has not been settled yet.
Among the various integrin-type LM receptors described in 
the thymus, VLA-6 (α6β1 or CD49f/CD29) is the most studied; 
being expressed by developing thymocytes, in their various CD4/
CD8-defined subsets, as well as thymic microenvironmental 
cells, particular TEC. Nevertheless other LM receptors, such as 
α3β1 and α6β4, are also constitutively expressed by developing 
thymocytes and TEC (30, 57, 63, 71).
The intrathymic distribution of LM isoforms in normal condi-
tions is summarized in Table 2, whereas the expression of some 
integrin-type LM receptors by thymic cells is seen in Table 3.
ROLe OF LMs iN THYMOCYTe 
MiGRATiON
LM-Mediated interactions as a vector 
influencing Thymocyte Migration
Migration within a solid tissue requires transient adhesion of 
migrating cells on the cellular and ECM substrates. Accordingly, 
adhesion assays, as well as migration assays using transwell migra-
tion chambers have been extensively used to test whether LMs are 
involved in thymocyte migration. Moreover, we have used TNC 
to study migration of developing thymocytes in the context of 
the tridimensional structure of these lymphoepithelial complexes 
(76). TNC can be isolated from the thymus of various species and 
contain one TEC that harbor a variable number of thymocytes, 
mostly immature DP cells. These complexes can be settled in cul-
ture, where they progressively release thymocytes. Additionally, 
TNC-derived epithelial cells can be let in contact with immature 
thymocytes and re-form the classical TNC lymphoepithelial 
structures. Accordingly, evaluation of thymocyte release and 
reconstitution of TNC complexes may be applied to approach the 
exit and entrance of thymocytes in the epithelial niche.
We have showed that thymocyte adhesion onto TEC mon-
olayers is partially mediated by LM/VLA-6 interactions, being 
largely impaired in the presence of anti-CD49f monoclonal 
antibodies (63). Furthermore, when we treated mouse or human 
TEC with different stimuli that enhance LM production and 
LM receptor expression, we found an increase of thymocyte 
adhesion; an effect that could be prevented by anti-LM or anti-
CD49f antibodies (63, 77–79). This interaction is also blocked 
by monoclonal antibodies specific for integrin α6β1 and its 
LM ligand LM-211 (57). This is similar to the previous studies 
performed in the mouse thymus showing that the thymocyte 
adhesion onto LM-211 could be abrogated by anti-CD49f or 
anti-CD29 antibodies (recognizing α6 and β1 integrin chains, 
respectively) (30). LM-111 as well as LM-211 can also modulate 
thymocyte trafficking in TNC complexes, stimulating both 
the entrance and exit of thymocytes in cultures of the TNC 
lymphoepithelial complexes, and such migratory patterns could 
be blocked with anti-CD49f antibodies recognizing α6 integrin 
chain (19, 63, 77).
We have proposed a model termed multivectorial thymocyte 
migration. Accordingly, a vector represents, as in Physics, a force 
that has magnitude and direction (and can be associated to other 
vectors) acting upon an object. In this sense, the oriented move-
ment of developing thymocytes  –  resulting from cell velocity 
and displacement in a given moment and in a particular thymic 
zone  –  might be a resulting vector from individual migrating 
vectors, which represent the various ligand–receptor interactions 
that influence thymocyte migration (18, 80, 81). This model can 
be seen in Figure 1B. Moreover, using ex vivo migration assays, 
we found that a given cell migration-related ligand/receptor pair 
interaction can modulate another pair (82–84), thus rendering 
the model still much more complex.
Laminin-mediated interactions can be placed as an individual 
vector in the multivectorial model (or group of vectors depending 
on each isoform), inducing thymocyte migration and conse-
quently differentiation, contributing to the final resulting vector, 
alone or combined with other molecules, as we further discuss 
below. This is illustrated in Figure 1B.
It is well described that LM (in this case LM-111) induces 
mouse thymocyte haptotaxis in ex vivo assays using freshly 
isolated thymocytes (18, 82, 83). Also, experiments using mouse 
LM-111 revealed that LM-mediated interactions are relevant for 
the entrance of T-cell precursors into the thymus (19, 85), for the 
migration of developing thymocytes, both in mice and humans 
(57, 68, 86), as well as in peripheral lymphoid organs (87, 88).
FiGURe 2 | effects of integrin α6 knockdown on cell adhesion and 
migration-related genes of human thymic epithelium. The figure shows 
extracellular matrix and chemokine ligand genes up- and downregulated 
after integrin α6 (ITGA6) knockdown by small interference RNA (siRNA) 
strategy. Gene expression was defined using PCR arrays, comparing ITGA6 
siRNA-treated thymic epithelial cells (n = 5) with control siRNA cells (n = 5). 
Bar colors indicate different group of genes (LM chains and FN in green, 
integrin sub-unities in purple, chemokines in orange and cytokines in blue). 
Right bars are upregulated genes and left bars are downregulated genes, 
both showed in percentage. Two-tailed unpaired Student’s t-test was 
applied, and the differences showed were all significant. Data derived from 
Ref. (72).
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Data from mouse and human models revealed that LM-211 
also exerts a haptotactic effect upon normal thymocyte migra-
tion, as revealed by ex vivo transmigration assays, as well as by 
in vitro thymocyte entrance and exit of TNC lymphoepithelial 
complexes. Again, this interaction is also blocked by mono-
clonal antibodies specific for integrin α6β1 and its LM ligand 
LM-211 (57). This is similar to the previous studies performed 
in the mouse thymus showing that the thymocyte adhesion 
onto LM-211 could be abrogated by anti-CD49f or anti-CD29 
antibodies (30). Additionally, in the human model, it was 
showed that thymocyte adhesion can be impaired by anti-α3 
integrin chain antibodies (57), strongly indicating that LM-211 
can modulate thymus physiology by using at least two distinct 
LM-binding integrins.
More recently, we applied the RNA interference (RNAi) 
approach to study the role of integrin-type ECM receptors upon 
the thymic epithelium and the resulting interactions with devel-
oping thymocytes (72, 89). Modulation in both gene and pro-
tein expressions affecting LM-mediated interactions has been 
reported influencing thymocytes. For example, RNAi-induced 
knockdown of the ITGA6 gene in cultured human TEC induced 
a significant decrease in CD49f membrane expression, with 
consequent decrease in the adhesion of these cells to LM and to 
cultured TEC. Moreover, we found up- and downregulation of 
a large number of cell migration-related genes, including those 
encoding LM chains, integrin sub-unities, as well as chemokine 
and cytokines; some of them are illustrated in Figure 2 (72). In 
this case, genetic modulation provided important information 
on the regulatory relation between the α6 integrins and thymic 
epithelium adhesion and migration genes. These data clearly 
show that downregulation of ITGA6 gene in the human thymic 
epithelium triggers a complex cascade of effects upon the expres-
sion levels of several other cell migration-related genes, includ-
ing ECM and chemokine ligands and receptors. Taken together, 
these data unravel the concept that the expression of genes 
involved in controlling of thymocyte migration by the thymic 
microenvironment should be regarded as complex networks, 
so that a defect in the expression of one single gene may reflect 
in an amplified cascade with functional consequences for TEC 
adhesion onto the natural ligand and potential consequences 
upon the normal patterns of TEC/thymocyte interactions.
Other Cell Migration-Related vectors Act 
Synergistically with LM on Thymocyte 
Migration
One new interesting topic of study approaches the possibil-
ity that other factors could act synergistically with LM and 
significantly influence thymocyte migration. In this context, 
LM-111 can enhance the chemotactic activity of chemokines 
when both molecules are placed in combination in transmigra-
tion chambers. The CXCL12 chemokine per  se also induces 
thymocyte migration, but when combined with LM a synergic 
migratory response can be observed in different thymocyte sub-
populations, mainly the immature DP cells Figures 3A,B (90). 
Interestingly, a synergic effect was also observed for LM com-
bined with other chemokines as CCL22 and CCL19, but in this 
case the more responsive subpopulations were mature CD4 and 
CD8 SP thymocytes.
These observations suggest that LM can enhance respon-
siveness to chemokines but depending on the combination of 
molecules, the response is more evident in specific thymocyte 
subsets. Nevertheless, these effects were measured using 
LM-111, and so far we do not know whether other LM iso-
forms act similarly. Nevertheless, these data point to a possible 
bidirectional influence between a given migration vector and 
LM-mediated interaction upon thymocyte migration. Yet, 
further studies are warranted to mechanistically approach such 
a hypothesis.
FiGURe 3 | Laminin receptor expression and laminin-driven migration of mouse thymocytes: relationship with CXCL12/CXCR4 interactions.  
(A) depicts a dot plot derived from four-color cytofluorometric immunostaining of mouse thymocytes. The panel shows the simultaneous membrane expression of 
CD49f (α6 integrin chain) and CXCR4, the CXCL12 chemokine receptor, in the four CD4/CD8-defined thymocyte subsets. In this panel, it is clear that in all immature 
and thymocyte thymocyte subpopulations, there are cells expressing both receptors. The numbers seen in each dot blot represent the percentages of cells 
expressing either CD49f and/or CXCR4 in each CD4/CD8-defined thymocyte subset. (B) reveals that thymocytes migrate toward CXCL12 and LM-111, as 
compared to bovine serum albumin (BSA), used as negative control. Interestingly, when migratory stimuli were applied simultaneously, the resulting migration was 
higher than the sum of each stimulus used alone, strongly indicating synergy between LM and CXCL12 to stimulate cell migration. Data derived from Ref. (19).
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Hormonal Control of LM-Mediated 
Thymocyte Migration
Laminin and VLA-6 expression in the thymus can be upregulated 
by hormones such as the growth hormone (GH) (88). We initially 
showed that GH treatment of human TEC enhances LM produc-
tion, the expression of LM, with consequent increased adhesion 
of thymocytes to treated TEC, and also the release of thymocytes 
from TNC; effects that could be abrogated by anti-LM and anti-LM 
receptor antibodies (79). In vivo studies showed that thymocytes 
from GH-transgenic mice, or from control mouse thymus injected 
with GH, migrate more through LM, but not through fibronectin 
(FN), when comparing to controls (82, 91). The combination 
of LM with CXCL12 synergized migratory responses, and this 
phenomenon could be observed in all thymocyte subpopulations. 
Interestingly enough, treatment with pertussis toxin (which 
catalyzes Gαi ADP-rybosilation, therefore resulting in signaling 
inhibition of G protein-coupled receptors, including chemokine 
receptors) prior to ex vivo migration assays blocked the migration 
of both control and GH-transgenic mouse thymocytes but did 
not change the profiles of LM-triggered thymocyte migration. 
However, when thymocytes from GH-transgenic mice were 
preincubated with anti-VLA-6-blocking mAb (that recognizes 
the CD49f chain) and then subjected to CXCL12 stimulation, 
a decrease in the numbers of migrating cells is observed (82). 
These results reinforce the idea of a crosstalk between integrins 
and chemokine receptors and the fact that the relative influence 
of VLA-6 on the CXCR4 signaling pathway seems to be more 
relevant than the reverse situation.
Triiodothyronine (T3), a thyroid hormone critical for the 
regulation of body metabolism, growth, and development, also 
exerts several effects on thymus physiology. Mice treated with 
T3 exhibited an increase in thymus weight and cellularity and an 
enhancement in the intrathymic expression of ECM and ECM 
receptors on thymocytes, including LM and VLA-6, respectively 
(92–94). Consequently, after short- and long-term T3 treatments, 
migration of thymocytes through LM is increased in ex vivo 
assays, proportionally to the treatment. Moreover, T3 stimulates 
thymocyte egress to peripheral lymphoid organs. Recent thymic 
emigrants (RTE) were evaluated by flow cytometry in the spleen, 
subcutaneous, and mesenteric lymph nodes 16 h after intrathymic 
FITC injection, and it was observed that T3 treatment changed 
the distribution of RTE among lymphoid organs, directing cells 
to lymph nodes instead of the spleen (95). These findings indi-
cate that T3, by enhancing migratory capacity of thymocytes in 
response to LM, can redirect lymphocyte homing in the periphery.
Glucocorticoid (GC) hormones also regulate intrathymic 
LM-mediated interactions. Mice injected with GCs exhibit a rapid 
thymocyte depletion, which is paralleled by an enhancement of 
LM deposition within both cortical and medullary regions of 
the thymic lobules. Such an effect is not only due to the atrophy 
of the organ, since treating cultured TEC with dexamethasone 
also enhances LM production (52). Additionally, developing 
thymocytes from GC-treated mice exhibit a higher membrane 
expression of the CD49f chain of LM receptor (63). Moreover, GC 
treatment on cultured TEC enhances LM production, increases 
thymocyte adhesion, as well as the release of thymocytes from 
TNC complexes; effects that can be reversed by anti-CD49f anti-
body treatment (63). Overall, these data showed that GC is able 
to modulate cell migration-related LM-mediated interactions in 
the thymus. Nevertheless, it is to be determined if GC per se can 
directly induce thymocyte migration or act via the effect on TEC.
OTHeR MOLeCULeS CONTROLLiNG 
LM-MeDiATeD MiGRATiON
The expression of some molecules initially described in the nerv-
ous system, such as neuropilins (NRPs) and ephrins, can also be 
observed in the thymus. Interestingly, these molecules were also 
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shown to play a role in thymocyte migration and in modulating 
LM-induced haptotactic responses.
Neuropilins are transmembrane glycoprotein receptors for 
secreted class 3 semaphorins (Semas) and some vascular endothe-
lial growth factor isoforms (96). Several NRP/Sema receptor/
ligand pairs are expressed in the mouse and human thymuses, 
in both lymphoid and non-lymphoid compartments (97). The 
expression patterns of NRPs and Semas, such as NRP1/Sema3A, 
suggests their involvement in numerous cell processes in the 
thymus, including thymocyte adhesion and migration. Sema3A 
treatment, for example, decreases the adhesion of human NRP1+ 
thymocytes on TEC monolayers (83). Moreover, Sema3A exerts 
a dose-dependent chemorepulsive effect on human thymocytes, 
and it inhibits LM-induced thymocyte migration (83). Yet, this 
inhibitory effect is not restricted to LM, since Sema3A treatment 
also abrogates FN or CXCL12-driven migration of all CD4/CD8-
defined thymocyte subsets (95).
Ephrins are also expressed in numerous cell types, including 
TEC and thymocytes, and bind the Eph receptor family, which 
corresponds to the largest family of tyrosine-kinase receptors in 
animal cells (98). In the thymus, it has been demonstrated that 
Eph/Ephrins signaling is relevant for cell migration, including the 
entry of bone marrow progenitor cells, migration of thymocytes 
within the organ and thymocyte export, triggered by chemokines 
and/or ECM proteins, including LM-111. Eph stimulation by 
ephrin B1 inhibits LM-111- and FN-driven migration responses 
as well as CXCL12-, CCL21-, and CCL25-induced chemotaxis 
of both bone marrow progenitors and thymocytes from normal 
mice (81, 85). The fact that LM-111 is involved in the entrance of 
T-cell precursors into the developing thymus is in keeping with 
previous data showing that anti-CD49f antibodies largely reduced 
the number of thymocytes in a mouse model of thymus coloniza-
tion by T-cell precursors (99). Yet, we do not know whether other 
LM isoforms are biologically active in promoting these effects.
Noteworthy, the prion cellular protein (PrPC) can also be found 
in the nervous and immune systems and can bind LM through its γ1 
chain (100–103). In the thymus, PrPC is physiologically expressed 
by mouse thymocytes and TEC. Although PrPC-deficient mice do 
not exhibit major changes in thymus physiology, PrPC overexpres-
sion has a major influence in thymocyte development, since PrPC 
transgenic mice show a severe thymic hypoplasia with thymocyte 
differentiation being largely blocked at immature stages (104). 
Moreover, the remaining immature thymocytes present impaired 
LM-driven migration, and this is paralleled by the fact that the 
number of CD4+ and CD8+ T cells in peripheral lymphoid organs 
is largely diminished (105). All together, these findings indicate 
that overexpression of PrPC generates a multifaceted disturbance 
in T-cell development, and change, at least via LM-driven interac-
tions, the general migration pattern of developing thymocytes, 
including their export from the organ.
Despite not being shown to directly interact with LM in the 
thymus, other ECM associated molecules that mediate thymocyte 
interactions via integrin-type LM receptors have been reported. 
Recently, the LM-related molecule named netrin-1, also initially 
described in the nervous system, was found to be expressed in 
thymic stromal cells and also in anti-CD3- or IL-7-stimulated 
thymocytes (106). Additionally, in vitro assays demonstrated that 
thymocytes strongly adhere to netrin-coated surfaces, in a man-
ner partially dependent on α6β4 integrin, and netrin was shown 
to potentiate CXCL12-driven chemotaxis of thymocytes (106).
Another matricellular protein called Cyr61/Ccn1, which binds 
α6β1 integrin (107), is produced by thymic microenvironmental 
cells (108), with TEC as the main source, and was shown to 
enhance both TEC proliferation and TEC–thymocyte interac-
tions (109).
expression of LM and its Possible Role on 
Thymocyte Migration in Disease
Infectious Diseases
In some pathological conditions, the expression/deposition of 
LM and LM receptors in the thymus can be modulated. These 
alterations can, in turn, alter thymocyte migration. This is the 
case of the Trypanosoma cruzi infection, the experimental model 
of Chagas disease. Thymuses from T. cruzi acutely infected mice 
present a severe atrophy, which is characterized by death of 
DP thymocytes by a caspase-dependent apoptosis mechanism 
(110–113). In parallel, we described a premature exit of immature 
DN and DP cells (which may have not been subjected to intra-
thymic selection processes) to peripheral lymphoid organs, and 
that persists in the chronic phase of Chagas disease, both in mice 
and humans (111, 114, 115). In keeping with these data is the fact 
that the release of immature thymocytes from TNC is enhanced 
after in vivo or in vitro T. cruzi infection (116). Considering that 
immature DP T cells abnormally released from the thymus have an 
activated phenotype (114), it is possible that thymocyte migration 
disturbances could be partially responsible for the tissue lesions 
observed in the pathophysiology of the disease. Interestingly, an 
enhanced deposition of LM is observed in the thymus of infected 
mice, as well as an increased expression of VLA-6 on both 
immature and mature thymocytes and of LM production by TEC 
(111, 117). Nevertheless, whether LM-mediated interactions play 
a role in the export of immature thymocytes is an issue to be 
determined. In any case, it does not seem to be dependent on the 
rise of circulating GC hormones seen in the acute infection (115, 
118, 119), since in vivo GC treatment in normal mice does not 
induce export of these immature thymocytes (111).
The thymus is also a target organ in Plasmodium berguei 
infection, with induction of organ atrophy, apoptosis-induced 
death of DP thymocytes, enhanced chemokine (CXCL12) 
and ECM contents (LM and FN), and modulation of ECM 
and chemokine receptor expression on thymocytes (120). 
Thymocytes from infected animals express lower amounts of 
VLA-6, mainly the immature DP ones. Conversely, the expres-
sion of chemokine receptors is augmented when comparing to 
non-infected animals. In this case, DP cells, which express lower 
amounts of VLA-6, migrate less through LM, while mature 
CD4 and CD8 SP cells migrate more. When combining LM 
with chemokines, it was observed that LM enhanced CXCL12 
and CCL25-induced migration of mature thymocytes from 
infected mice, suggesting that alterations in LM and chemokine 
expression, as well as their respective receptors, can modulate 
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thymic function and export of mature lymphocytes during P. 
berguei infection.
Although the results are clear, it is important to have in 
mind that these functional studies have been conducted using 
mouse LM-111, and we do not know whether similar migratory 
responses occur toward other LM isoforms, an issue that is wor-
thy to be investigated.
In a second vein, it should be pointed out that the thymus is 
a target organ in several viral, bacterial, and parasitic diseases 
[reviewed by Nunes-Alves et  al. (121) and Savino (122)], and 
studies should be performed in various human and animal mod-
els of disease in order to define if the alterations described above 
are specific to given infectious agents, or rather universal.
Type 1 Diabetes
The non-obese diabetic (NOD) mouse spontaneously develops 
type 1 autoimmune diabetes, which is mediated by T-cell-
dependent destruction of pancreatic insulin-producing beta-cells 
(123). Studies in prediabetic animals revealed that the thymus 
of NOD mice present several alterations, including a higher LM 
deposition and the formation of giant PVS filled with LM (inter-
mingled with other basement membrane proteins, such as type 
IV collagen and FN) and mature thymocytes that accumulate 
within the organ (18, 124–126).
Unfortunately, these immunolocalization studies have been 
conducted using anti-LM polyclonal reagents, and it remains 
to be determined if the intra-PVS LM network is formed by a 
particular LM isoform.
Thymocytes from NOD mice present lower levels of mem-
brane VLA-5 (a FN receptor), but a higher VLA-6 expression 
when comparing with C57BL/6 mice (18, 126). This higher 
expression was accompanied by enhanced LM-driven migration 
and LM-driven upregulation of CXCL12-induced migration 
of thymocytes. Interestingly, an opposite effect was observed 
with FN. The defect in VLA-5 expression was accompanied by 
a diminished CXCL12-induced migration through FN-coated 
membranes (18). As thymocytes accumulate in thymic PVS, it is 
conceivable that, although thymocytes interacting with LM are 
able to migrate toward chemokines, a preponderant role is played 
by the aberrant VLA-5 expression and the consequent decreased 
FN-driven migration capacity of NOD thymocytes. All together, 
these findings indicate that, in the NOD mouse thymus, different 
individual vectors, such as those mediated by FN and LM inter-
actions, regulate positively or negatively the resulting migratory 
response.
Another relevant point to have in mind is that, as mentioned 
before, these studies have been performed in prediabetic NOD 
mice, and it has not been defined if the same changes remain after 
overt diabetes has been settled in these animals.
In this respect, we have recently evaluated normal mice 
turned diabetic after a single injection of alloxan, a drug known 
to destroy insulin-producing cells in the pancreas. The distribu-
tion and density of LM in thymuses from diabetic animal group 
(3 days following alloxan injection) was increased in both cortical 
and medullary regions of the thymic lobules, as compared to 
controls. By contrast, there was a decrease in VLA-6 expression in 
developing thymocytes from diabetic mice, although the migra-
tory response of these thymocytes to LM was not altered, in the 
presence or absence of CXCL12 (127).
Overall, the data summarized above indicate that LM receptor 
expression as well as migratory responsiveness to LM may change 
before versus after overt diabetes. Nevertheless, this hypothesis 
should be taken with precaution since the experimental animals 
used were different.
Lastly, whether or not thymocytes from NOD or alloxan-
treated animals respond similarly to LM isoforms other than 
LM-111 has not been investigated so far, and is obviously a miss-
ing point that deserves to be investigated.
CONCLUDiNG ReMARKS
Cumulative data summarized herein clearly show that LMs and 
their integrin-type receptors are constitutively expressed in the 
thymus, and that LM-mediated interactions are comprised within 
the complex ligand/receptor molecular network that ultimately 
guide thymocytes in a fine-tuned oriented movement of devel-
oping thymocytes throughout the thymic lobules. If we use the 
multivectorial concept of intrathymic T-cell migration, it is clear 
that the LM-mediated interactions can be considered one vector 
(or group of vectors). Furthermore, this vector can be controlled 
by other vectors (such as those represented by semaphorin/NRP 
and Eph/Ephrin interactions) and can also influence other vec-
tors, as that mediated by CXCL12/CXCR4, and possibly many 
others.
It should be noted however that several issues should be 
elucidated. For instance, if there is a natural mutant dy/dy mouse, 
where thymocyte development is severely affected, studies on the 
thymus of genetically engineered animals, already produced by 
either conventional or conditional knockout strategies for other 
LM or LM receptor chains, have not been conducted so far. Such 
studies certainly represent an important open avenue for future 
research. Similarly, although we have silenced the ITGA6 gene 
in human-cultured TEC by specific small interference RNA and 
did find modulation of a large number of cell migration-related 
genes and a downregulatory effect upon TEC adhesion (72), this 
strategy has not been used in vivo, after direct injection within 
the thymus.
Another aspect deserving to be experimentally approached 
is whether or not there is functional redundancy of distinct LM 
isoforms in terms of the effects upon thymocyte migration.
Developing these issues will provide important clues for better 
define the precise role of LM-mediated interactions upon intra-
thymic T-cell migration and development in health and disease.
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